Pharmaceutical News

RSS

UCI study shows promise of metabolic therapy for autoimmune diseases

A glucosamine-like dietary supplement suppresses the damaging autoimmune response seen in multiple sclerosis, according to a UC Irvine study.

1 Oct 2011

Circadian subsidiary submits IND application to FDA to initiate VGX-100 study against cancer

Circadian Technologies Limited is extremely proud to announce that its 100% owned subsidiary, Vegenics Pty Ltd, has submitted an investigational new drug application to the U.S. Food and Drug Administration to initiate clinical studies of VGX-100.

1 Oct 2011

ADVENTRX holds Type A meeting with FDA to discuss Exelbine NDA

ADVENTRX Pharmaceuticals, Inc. announced today that it held a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the complete response letter (CRL) it received in August from the FDA regarding the Company's New Drug Application (NDA) for Exelbine (vinorelbine injectable emulsion) for the treatment of non-small cell lung cancer.

1 Oct 2011

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

Galectin Therapeutics Inc. today announced that it posted a new corporate presentation video to its website, www.galectintherapeutics.com, that highlights the Company's leadership position in developing galectin-inhibiting therapeutics to treat fibrosis and cancer.

30 Sep 2011

FDA, other regulatory and international partners complete International Internet Week of Action

The U.S. Food and Drug Administration and other regulatory and international partners have completed the International Internet Week of Action (IIWA), a cooperative effort to curb online sales and distribution of counterfeit and illegal medical products.

30 Sep 2011

MU researchers examine use of propranolol to improve primary traits linked with autism

Most drug therapy interventions for people with autism have targeted psychiatric problems, including aggression, anxiety and obsessive behavior. Now, University of Missouri researchers are examining the use of propranolol to improve the primary traits associated with autism - difficulty with normal social skills, language and repetitive behaviors.

30 Sep 2011

Study highlights importance of prior planning before introduction of new vaccines

Proper planning before the introduction of new vaccines into a developing country's active immunization program could prevent storage problems and transportation bottlenecks that decrease the availability of existing vaccines by as much as two-thirds, according to a University of Pittsburgh study.

30 Sep 2011

Patients with chronic hepatitis C less likely to take medications over time

Patients being treated for chronic hepatitis C become less likely to take their medications over time, according to a new study from the Perelman School of Medicine at the University of Pennsylvania.

30 Sep 2011

APhA encourages patients to discuss with pharmacist about pain and medications

In honor of Pain Awareness Month, the American Pharmacists Association (APhA) encourages patients to have an open discussion with their pharmacist about their pain and the medications they take for pain.

30 Sep 2011

Survey: 25% of employers have little or no understanding of specialty pharmacy, costs

Twenty-five percent of employers have little or no understanding of specialty pharmacy and 53 percent have only a moderate understanding of this challenging benefit according to a new survey released by the non-profit Midwest Business Group on Health (MBGH), one of the nation's leading business groups of private and public employers.

30 Sep 2011

Resveratrol inhibits proliferation of hormone resistant breast cancer cells

Cheers! A new research report appearing in the October 2011 issue of The FASEB Journal shows that resveratrol, the "healthy" ingredient in red wine, stops breast cancer cells from growing by blocking the growth effects of estrogen.

30 Sep 2011

Cocaine use linked to increased risk of open-angle glaucoma

A study of the 5.3 million men and women seen in Department of Veterans Affairs outpatient clinics in a one-year period found that use of cocaine is predictive of open-angle glaucoma, the most common type of glaucoma.

30 Sep 2011

Oral steroid users twice as likely to have severe vitamin D deficiency

People taking oral steroids are twice as likely as the general population to have severe vitamin D deficiency, according to a study of more than 31,000 children and adults by scientists at Albert Einstein College of Medicine of Yeshiva University.

30 Sep 2011

Invida, Sinclair IS launch two dermatology products in seven Asia-Pacific markets

Sinclair IS Pharma Plc, the international specialty pharmaceutical company, and Invida Holdings Private Limited, a leader in the commercialisation of specialty biopharmaceutical and healthcare products throughout Asia Pacific, announce that their partnership has already led to the launch of two Sinclair IS dermatology products in seven Asia-Pacific markets.

30 Sep 2011

AstraZeneca settles SEROQUEL XR patent infringement litigation

AstraZeneca today announced it has entered into a settlement agreement in its U.S. SEROQUEL XR patent infringement litigation against Handa Pharmaceuticals, LLC regarding Handa's proposed generic version of AstraZeneca's SEROQUEL XR extended-release tablets.

30 Sep 2011

Beta-blockers can prevent breast cancer metastasis and improve survival

Cancer Research UK scientists are investigating whether beta-blockers hold the key to preventing breast cancer spread and improving survival. Promising early results will be presented on the eve of breast cancer awareness month at the Royal Society of Medicine.

30 Sep 2011

Circadian files IND with FDA for VGX-100 for the treatment of cancer patients with solid tumors

Circadian Technologies Limited (ASX: CIR, OTCQX:CKDXY) is extremely proud to announce that its 100% owned subsidiary, Vegenics Pty Ltd, has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate clinical studies of VGX-100. The first trial (Phase I) will involve the treatment of a variety of different cancer types in patients with late stage cancer.

29 Sep 2011

Bulgaria’s decades old anti-smoking pill could be a cheap and effective answer to smoking cessation

A pill from Bulgaria during the Soviet era shows promise for helping millions of smokers cheaply and safely kick the habit, the first big clinical trial of it shows. It is unclear whether it will ever reach the market in the U.S. or Western Europe though.

29 Sep 2011

FDA CDER assigned for pre-market review of CorMedix's Neutrolin

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced that on September 15, 2011, the U.S. Food and Drug Administration advised CorMedix, that the Center for Drug Evaluation and Research has been assigned as the lead agency for the pre-market review of Neutrolin.

29 Sep 2011

Almirall seeks European approval for linaclotide to treat irritable bowel syndrome with constipation

Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.

29 Sep 2011

Pharmaceutical News

UCI study shows promise of metabolic therapy for autoimmune diseases

Circadian subsidiary submits IND application to FDA to initiate VGX-100 study against cancer

ADVENTRX holds Type A meeting with FDA to discuss Exelbine NDA

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

FDA, other regulatory and international partners complete International Internet Week of Action

MU researchers examine use of propranolol to improve primary traits linked with autism

Study highlights importance of prior planning before introduction of new vaccines

Patients with chronic hepatitis C less likely to take medications over time

APhA encourages patients to discuss with pharmacist about pain and medications

Survey: 25% of employers have little or no understanding of specialty pharmacy, costs

Resveratrol inhibits proliferation of hormone resistant breast cancer cells

Cocaine use linked to increased risk of open-angle glaucoma

Oral steroid users twice as likely to have severe vitamin D deficiency

Invida, Sinclair IS launch two dermatology products in seven Asia-Pacific markets

AstraZeneca settles SEROQUEL XR patent infringement litigation

Beta-blockers can prevent breast cancer metastasis and improve survival

Circadian files IND with FDA for VGX-100 for the treatment of cancer patients with solid tumors

Bulgaria’s decades old anti-smoking pill could be a cheap and effective answer to smoking cessation

FDA CDER assigned for pre-market review of CorMedix's Neutrolin

Almirall seeks European approval for linaclotide to treat irritable bowel syndrome with constipation

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News